Enterobacteriaceae

• 

  Subject Areas on Research

  • A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae. 
  • A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae. 
  • A novel murine model of inflammatory bowel disease and inflammation-associated colon cancer with ulcerative colitis-like features. 
  • A rapid, presumptive procedure for the detection of Salmonella in foods and food ingredients. 
  • An assessment of fecal indicator bacteria-based water quality standards. 
  • Analysis of two- and three-year trends in antimicrobial resistance in intensive care units using unit-specific antibiograms. 
  • Antibiotic-induced changes in the microbiota disrupt redox dynamics in the gut. 
  • Assessment and significance of bacterial overgrowth in the small bowel. 
  • Bacterial colonization of intravenous catheter materials in vitro and in vivo. 
  • Bacterial contamination associated with estuarine shoreline development. 
  • Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae? 
  • Can't take the heat: high temperature depletes bacterial endosymbionts of ants. 
  • Cefazolin as a class representative for oral cephalosporins and uncomplicated urinary tract infections caused by indicated Enterobacteriaceae. 
  • Cefditoren: Comparative efficacy with other antimicrobials and risk factors for resistance in clinical isolates causing UTIs in outpatients. 
  • Changing mesophilic wastewater sludge digestion into thermophilic operation at Terminal Island Treatment Plant. 
  • Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital. 
  • Clinical importance of polymicrobial bacteremia. 
  • Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients. 
  • Conservation of the D-mannose-adhesion protein among type 1 fimbriated members of the family Enterobacteriaceae. 
  • Control of diarrhoeal diseases. 
  • Control of simultaneous outbreaks of carbapenemase-producing enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and Prevention 2012 carbapenemase-resistant Enterobacteriaceae Toolkit. 
  • Controlled comparison of the BacT/Alert and BACTEC 660/730 nonradiometric blood culture systems. 
  • Controlled evaluation of 5 versus 10 milliliters of blood cultured in aerobic BacT/Alert blood culture bottles. 
  • Controlled evaluation of the agar-slide and radiometric blood culture systems for the detection of bacteremia and fungemia. 
  • Dynamic linear models guide design and analysis of microbiota studies within artificial human guts. 
  • Enteric infection and inflammation alter gut microbial ecology. 
  • Epidemiology and molecular characterisation of metallo-β-lactamase-producing Enterobacteriaceae in a university hospital Intensive Care Unit in Greece. 
  • Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study. 
  • Evaluation of CHROMagar™ KPC for the detection of carbapenemase-producing Enterobacteriaceae in rectal surveillance cultures. 
  • Evaluation of different laboratory tests for the detection of metallo-beta-lactamase production in Enterobacteriaceae. 
  • Fe(III) coordination properties of two new saccharide-based enterobactin analogues: methyl 2,3,4-tris-O-[N-[2,3-di(hydroxy)benzoyl-glycyl]-aminopropyl]-alpha-D-glucopyranoside and methyl 2,3,4-tris-O-[N-[2,3-di-(hydroxy)-benzoyl]-aminopropyl]-alpha-D-glucopyranoside. 
  • FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae. 
  • Genome evolution in an insect cell: distinct features of an ant-bacterial partnership. 
  • Genome sequence of Blochmannia pennsylvanicus indicates parallel evolutionary trends among bacterial mutualists of insects. 
  • Gut microbes out of control in HIV infection. 
  • High susceptibility of MDR and XDR Gram-negative pathogens to biphenyl-diacetylene-based difluoromethyl-allo-threonyl-hydroxamate LpxC inhibitors. 
  • Host-symbiont stability and fast evolutionary rates in an ant-bacterium association: cospeciation of camponotus species and their endosymbionts, candidatus blochmannia. 
  • Hypoxia-independent activation of HIF-1 by enterobacteriaceae and their siderophores. 
  • Infectious complications following endoscopic retrograde cholangiopancreatography: an automated surveillance system for detecting postprocedure bacteremia. 
  • Interpretive criteria and quality control limits for ceftibuten disk susceptibility tests. Collaborative Antimicrobial Susceptibility Testing Group. 
  • Laboratory investigation of diarrhea in travelers to Mexico: evaluation of methods for detecting enterotoxigenic Echerichia coli. 
  • Mast cell modulation of the innate immune response to enterobacterial infection. 
  • Mast cell phagocytosis of FimH-expressing enterobacteria. 
  • Modeling the relationship between most probable number (MPN) and colony-forming unit (CFU) estimates of fecal coliform concentration. 
  • Modified Hodge test versus indirect carbapenemase test: prospective evaluation of a phenotypic assay for detection of Klebsiella pneumoniae carbapenemase (KPC) in Enterobacteriaceae. 
  • Molecular dissection of an outbreak of carbapenem-resistant enterobacteriaceae reveals Intergenus KPC carbapenemase transmission through a promiscuous plasmid. 
  • Motility-indole-lysine medium for presumptive identification of enteric pathogens of Enterobacteriaceae. 
  • Motility-indole-lysine-sulfide medium. 
  • Nonhomogeneous model of sequence evolution indicates independent origins of primary endosymbionts within the enterobacteriales (gamma-Proteobacteria). 
  • Ofloxacin, a new broad-spectrum fluoroquinolone. Results from a Multicenter, National Comparative Activity Surveillance Study. The Ofloxacin Surveillance Group. 
  • Outcome of Pediatric Gastroenterology Outpatients With Fever and Central Line. 
  • Patterns of fecal coliform contamination in day-care centers. 
  • Plasmid-mediated quinolone resistance determinants among Gram-negative bacteraemia isolates: a hidden threat. 
  • Prevalence of 16S rRNA methylase genes in Enterobacteriaceae isolates from a Greek university hospital. 
  • Proteomic analysis of an unculturable bacterial endosymbiont (Blochmannia) reveals high abundance of chaperonins and biosynthetic enzymes. 
  • Quicker determination of antibiotic susceptibility in urinary tract infections. 
  • Rahnella aquatilis, an unusual gram-negative rod isolated from the bronchial washing of a patient with acquired immunodeficiency syndrome. 
  • Reduced nicotinamide adenine dinucleotide phosphate-sulfite reductase of enterobacteria. 3. The Escherichia coli hemoflavoprotein: catalytic parameters and the sequence of electron flow. 
  • Reduced nicotinamide adenine dinucleotide phosphate-sulfite reductase of enterobacteria. IV. The Escherichia coli hemoflavoprotein: subunit structure and dissociation into hemoprotein and flavoprotein components. 
  • Reduced nicotinamide adenine dinucleotide phosphate-sulfite reductase of enterobacteria. V. Studies with the Escherichia coli hemoflavoprotein depleted of flavin mononucleotide: distinct roles for the flavin adenine dinucleotide and flavin mononucleotide prosthetic groups in catalysis. 
  • Reduced nicotinamide adenine dinucleotide phosphate-sulfite reductase of enterobacteria. VI. The reaction of carbon monoxide with the Escherichia coli holoenzyme, the hemoprotein, and free siroheme. 
  • Reevaluation of Clinical and Laboratory Standards Institute disk diffusion breakpoints for tetracyclines for testing Enterobacteriaceae. 
  • Remaining flexible in old alliances: functional plasticity in constrained mutualisms. 
  • Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria. 
  • Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States. 
  • Sampling out: regulatory avoidance and the Total Coliform Rule. 
  • Sequence context of indel mutations and their effect on protein evolution in a bacterial endosymbiont. 
  • Slip into something more functional: selection maintains ancient frameshifts in homopolymeric sequences. 
  • The MAL-ED study: a multinational and multidisciplinary approach to understand the relationship between enteric pathogens, malnutrition, gut physiology, physical growth, cognitive development, and immune responses in infants and children up to 2 years of age in resource-poor environments. 
  • The function of antibody and complement in the lysis of bacteria. 
  • Treating infections caused by carbapenemase-producing Enterobacteriaceae. 
  • United States geographic bacteria susceptibility patterns. 1996 ASCP Susceptibility Testing Group. American Society of Clinical Pathologists. 
  • Unprecedented loss of ammonia assimilation capability in a urease-encoding bacterial mutualist. 
  • Utility of a clinical risk factor scoring model in predicting infection with extended-spectrum β-lactamase-producing enterobacteriaceae on hospital admission. 
  • Water quality at points-of-use in the Galapagos Islands. 
  • When should contact precautions and active surveillance be used to manage patients with multidrug-resistant enterobacteriaceae?